(Q33500303)

English

Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC). (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sophie D. Fosså

3

object named as

S Fossa

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

object named as

C N Sternberg

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

P de Mulder

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

S Kaye

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

T Roberts

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A Pawinsky

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

S Daamen

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

695-696

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The treatment of advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

Lobaplatin in combination with methotrexate and vinblastine in patients with transitional cell carcinoma of the urinary tract--a pilot phase I/(II) study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008269432176

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008269432176

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33500303&oldid=2186386783"